http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111575370-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea54c5988c1072efa1069ec3c6a6c88d |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
filingDate | 2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_692d21cf569dfa7426fd9a3a0279bc40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7ce7f1b356b3dccd8c3939055d1e878 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70b14bfba4dfd2ed8e78f6dcab617aa1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_690f12530dc24ce30c09d8ec01c3031b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e22c83acd599090b22533730b8dedf82 |
publicationDate | 2020-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111575370-A |
titleOfInvention | Artificial mimic nucleic acid molecular beacon and kit for detecting polymorphism of site rs7853758 of SLC28A3 gene |
abstract | The invention discloses a typing detection method and a kit for the polymorphism of the rs7853758 locus of an SLC28A3 gene. The SLC28A3 gene specific primers SEQ1 and SEQ2 are adopted to amplify an SLC28A3 gene fragment, and SLC28A3 gene specific artificial analogue nucleic acid molecular beacons SEQ3-FAM and SEQ4-VIC are designed in an amplification region defined by the SLC28A3 gene specific primers. The method for judging the polymorphism of the rs7853758 locus of the SLC28A3 gene based on the gene specificity PCR combined with the artificial simulated nucleic acid molecular beacon, which is provided by the invention, has the advantages of high accuracy, high detection speed, simplicity in operation, objective result interpretation, less closed-tube reaction pollution and the like, and is very suitable for large-scale clinical development. |
priorityDate | 2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.